|By PR Newswire||
|August 29, 2014 06:59 PM EDT||
DUBLIN, Ireland, August 29, 2014 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/jjj5vs/global_peptic) has announced the addition of the "Global Peptic Ulcer Drugs Market 2014-2018" report to their offering.
A peptic ulcer is an open lesion that develops on the mucosal lining of the stomach and small intestine because of the caustic effect of the gastric acids and enzymes in these organs. The symptoms of peptic ulcers are pain in the abdomen, nausea, vomiting, and bloated stomach. The major symptoms include bleeding from the ulcer, which can be life-threatening. It is detected by bloody and sticky stools, often black in color. Peptic ulcers are caused mainly by a Helicobacter pylori infection followed by the overuse of OTC NSAIDs such as Naproxen, Aspirin and Ibuprofen. Peptic ulcers can be of two types based on the site of the ulcer: gastric ulcer and duodenal ulcer.
The analysts forecast the Global Peptic Ulcer Drugs market to grow at a CAGR of 2.9 percent over the period 2013-2018.
This report covers the present scenario and the growth prospects of the Global Peptic Ulcer Drugs market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various drugs used in the treatment of peptic ulcers that are available in the market.
Key Topics Covered:
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
04. Product Profiles
05. Market Research Methodology
07. Market Landscape
08. Pipeline Portfolio
09. Market Segmentation by Class of Drugs
10. Geographical Segmentation
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Trends and their Impact
18. Vendor Landscape
19. Key Vendor Analysis
- AstraZeneca plc
- Eisai Co. Ltd.
- Daewoong Pharmaceutical Co. Ltd.
- Takeda Pharmaceutical Co. Ltd.
- Daiichi Sankyo
- Dr. Reddy's Laboratories
- Ferring Pharmaceuticals
- Horizon Pharma
- Johnson and Johnson
- Merck Sharp and Dohme
- Otsuka Holdings
- Rottapharm Madaus
- Taiho Pharmaceutical
- Zeria Pharmaceutical and Zuventus Healthcare
For more information visit http://www.researchandmarkets.com/research/jjj5vs/global_peptic
Media Contact: Laura Wood , +353-1-481-1716, [email protected]
DevOps is being widely accepted (if not fully adopted) as essential in enterprise IT. But as Enterprise DevOps gains maturity, expands scope, and increases velocity, the need for data-driven decisions across teams becomes more acute. DevOps teams in any modern business must wrangle the ‘digital exhaust’ from the delivery toolchain, "pervasive" and "cognitive" computing, APIs and services, mobile devices and applications, the Internet of Things, and now even blockchain.
Feb. 24, 2017 03:45 PM EST Reads: 1,368
WebRTC is the future of browser-to-browser communications, and continues to make inroads into the traditional, difficult, plug-in web communications world. The 6th WebRTC Summit continues our tradition of delivering the latest and greatest presentations within the world of WebRTC. Topics include voice calling, video chat, P2P file sharing, and use cases that have already leveraged the power and convenience of WebRTC.
Feb. 24, 2017 03:45 PM EST Reads: 1,202
A strange thing is happening along the way to the Internet of Things, namely far too many devices to work with and manage. It has become clear that we'll need much higher efficiency user experiences that can allow us to more easily and scalably work with the thousands of devices that will soon be in each of our lives. Enter the conversational interface revolution, combining bots we can literally talk with, gesture to, and even direct with our thoughts, with embedded artificial intelligence, whic...
Feb. 24, 2017 03:30 PM EST Reads: 1,351
Feb. 24, 2017 03:15 PM EST Reads: 1,059
SYS-CON Events announced today that CA Technologies has been named “Platinum Sponsor” of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY, and the 21st International Cloud Expo®, which will take place October 31-November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. CA Technologies helps customers succeed in a future where every business – from apparel to energy – is being rewritten by software. From ...
Feb. 24, 2017 03:15 PM EST Reads: 2,081
Feb. 24, 2017 02:45 PM EST Reads: 1,811
Feb. 24, 2017 02:15 PM EST Reads: 8,429
Feb. 24, 2017 02:15 PM EST Reads: 840
Feb. 24, 2017 02:00 PM EST Reads: 1,905
Feb. 24, 2017 01:45 PM EST Reads: 1,053
Feb. 24, 2017 01:15 PM EST Reads: 736
Feb. 24, 2017 01:00 PM EST Reads: 1,876
Feb. 24, 2017 01:00 PM EST Reads: 1,414
Feb. 24, 2017 12:30 PM EST Reads: 1,334
Feb. 24, 2017 12:30 PM EST Reads: 2,528